Form 4: Health In Tech Director Chike Umemezia Acquires Restricted Stock Grant

Health In Tech, Inc. Director Chike Umemezia was granted 128,474 restricted shares of Class A Common Stock at $0.62 per share, vesting based on service.

Summary

• Chike Umemezia, a Director of Health In Tech, Inc. (HIT), acquired 128,474 shares of Class A Common Stock.
• The transaction occurred on June 23, 2025.
• These shares are restricted stock, granted under the Health in Tech Equity Incentive Plan.
• The shares were valued at $0.62 per share at the time of grant.
• Vesting conditions include full vesting after one year of service commencing on December 23, 2024, or partial vesting at the first shareholders' meeting based on a pro-rata service period, contingent on continuous service.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is generally a positive sign, indicating alignment of interests and a commitment to long-term performance, though it's a routine compensation event rather than a major strategic announcement.

Positives

• The granting of restricted stock to a director aligns management's interests with shareholders, incentivizing long-term performance.
• The existence of an equity incentive plan suggests a structured approach to employee and director compensation.

Risks

• The value of the restricted stock is subject to the future performance of Health In Tech, Inc.'s stock price.
• Vesting is contingent on continuous service, meaning the director must remain with the company to fully realize the benefit.

Future Outlook

The vesting schedule for the restricted shares indicates a future commitment from the director, with full vesting contingent on one year of service from December 23, 2024, or partial vesting at a future shareholders' meeting.

Industry Context

The granting of restricted stock to directors is a common practice in the technology and healthcare sectors to align executive incentives with long-term company performance and shareholder value.

Comparison to Industry Standards

• The use of restricted stock grants is a standard compensation mechanism across various industries, including healthcare technology, to retain key personnel and incentivize long-term commitment.
• While specific comparable companies or projects are not detailed in this filing, such grants are typical for directors in companies of similar size and stage to Health In Tech, Inc.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially leading to better long-term performance. It also represents a potential dilution if new shares are issued, which is standard for equity incentive plans.
• Employees: The existence of an 'Equity Incentive Plan' suggests similar opportunities may exist for other employees, potentially boosting morale and retention.

Next Steps

• Continued service by the director until December 23, 2025, for full vesting of the restricted shares.
• Potential partial vesting at the first shareholders' meeting if full vesting conditions are not met by the initial date.

Key Dates

Recommendation

Keywords

Health In Tech, HIT, SEC Form 4, Insider Trading, Restricted Stock, Equity Incentive Plan, Director Compensation, Stock Grant, Chike Umemezia